|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.12 USD | +7.69% |
|
0.00% | +9.80% |
| 03-18 | Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
| 03-05 | Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL | CI |
Organicell Regenerative Medicine, Inc. reported earnings results for the full year ended October 31, 2023. For the full year, the company reported sales was USD 4.56 million compared to USD 6.49 million a year ago. Net loss was USD 6.99 million compared to USD 8.9 million a year ago.
Basic loss per share was USD 0.99 compared to USD 1.56 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.80% | 6.86M | |
| +19.79% | 71.69B | |
| -2.57% | 23.65B | |
| +9.05% | 9.01B | |
| +11.24% | 8.64B | |
| -18.91% | 8.15B | |
| +13.19% | 5.33B | |
| +17.83% | 4.35B | |
| -2.11% | 4.1B | |
| -1.92% | 3.94B |
ZEO SCIENTIFIX, INC. 
